Rituxan 500 MG/50 ML vial 50ML

Ended Awarded

Contract number
SPE2DR26FGFF3
Awardee
Awarding agency
Obligated
$23,690

Award facts

Contract value 100% obligated
$23,689.76 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Park Ridge, IL 60068, USA

Award details come from SAM.gov/FPDS.

About this award

Written by GovTribe AI ·

The Defense Logistics Agency issued a $23,689.76 delivery order to DMS Pharmaceutical Group Inc. on June 2, 2026, for Rituxan 500 mg/50 mL vials under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V).

DMS Pharmaceutical is a woman-owned small business. The order is a firm fixed-price call against the underlying single-award indefinite delivery contract (SPE2DX) with a $499.999 billion ceiling and ultimate completion date of December 31, 2036. Place of performance is Park Ridge, Illinois. The delivery order's ultimate completion date is June 24, 2026.

Quick answers

Who was awarded contract SPE2DR26FGFF3?

SPE2DR26FGFF3 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on June 2, 2026.

How much is contract SPE2DR26FGFF3 worth?

The government has obligated $23,690 on SPE2DR26FGFF3.

Is contract SPE2DR26FGFF3 an order under another contract?

Yes. SPE2DR26FGFF3 is a delivery order under SPE2DR25D9312, an indefinite delivery contract.

Was contract SPE2DR26FGFF3 competed?

The extent of competition for SPE2DR26FGFF3 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login